P86
Global practice patterns in hepatitis D virus screening and management: Results from an international survey of healthcare providers
M. Papatheodoridi, M. Buti, G. Papatheodoridis, P. Charatcharoenwitthaya, A. Bhadoria, J. Fan, B. Pearlman, C. Villela-Nogueira, S. Singh, S. Kakizaki, W. Chan, A. Kulkarni, A. Singal, A. Ostojić, J. Crespo, C. Tzeuton, J. Lai, L. Kondili, M. Batmunkh, M.
P92
Performance evaluation of the Cobas HDV assay for automated HDV RNA detection and quantification: implications for clinical diagnostics and treatment monitoring in patients with HDV infection
A. Kessler, S. Suresh Kumar, S. Giraldez Martinez, S. Zenebe Gebreab, M. Lin, J. Young, A. Hiergeist, B. Seiverth, C. Voitenleitner, P. Lampertico, M. Luet-gehetmann
P95
Quantitative anti-HDV measurement as a diagnostic surrogate of HDV replication
GP. Caviglia, E. Dileo, G. Gioiello, A. Olivero, G. Mengozzi, A. Ciancio, G. Ricco, B. Coco, L. Marinaro, G. Cariti, C. Taibi, G. D’Offizi, R. Cotugno, GA. Niro, A. Loglio, M. Viganò, C. Magni, D. Angrisani, V. Messina, V. Cossiga, M. Milella, G. Verucchi
P98
Clinical performances of the Roche Cobas HDV RNA quantification assay in untreated and Bulevirtide-treated CHD patients: a 4-assay comparati-ve study
MP. Anolli, S. Uceda Renteria, E. Degasperi, F. Facchetti, D. Sambarino, M. Borghi, R. Perbellini, R. Soffredini, S. Monico, A. Callegaro, P. Lampertico